https://doi.org/10.55788/74072edb
Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Zavegepant nasal spray effective for the acute treatment of migraine Next Article
Sustained long-term effect of occipital nerve stimulation in MICCH »
« Zavegepant nasal spray effective for the acute treatment of migraine Next Article
Sustained long-term effect of occipital nerve stimulation in MICCH »
Table of Contents: EHC 2022
Featured articles
EHF consensus on effective migraine treatment and triptan failure
IHS President: “It is time for operationalisation of ICHD”
Headache Prevention
Idiopathic intracranial hypertension: key factors influencing visual outcomes
Patients with migraines smoke less, drink less, and use fewer illicit drugs than general population
Headache Prophylaxis
Intervention
EHF consensus on effective migraine treatment and triptan failure
Sustained long-term effect of occipital nerve stimulation in MICCH
Onabotulinumtoxin A effective in older patients with chronic migraine
What to do when conventional treatment of headache fails in children
Predicting response to medical and surgical treatment of trigeminal neuralgia
Breakthroughs in Understanding Headache
IHS President: “It is time for operationalisation of ICHD”
GWAS identifies 7 loci for cluster headache
Towards precision medicine: salivary CGRP and erenumab response
Persistent headache after stroke: not rare and often overlooked
Additional effects of gepants on top of erenumab
Related Articles
July 30, 2019
Fremanezumab efficacy and safety maintained over 1 year
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy